Thomas Ach Roche, Novartis, Bayer, Nidek, Code C (Consultant/Contractor), Nidek, Code F (Financial Support), MacRegen, Code I (Personal Financial Interest), Novartis, Nidek, Code R (Recipient);
Geena Rennen None;
Raffael Liegl Novartis, Code C (Consultant/Contractor);
Kenneth Sloan None;
Frank Holz Acucela, Apellis, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, Roche/Genentech, Geuder, Gray, Gyroscope, Heidelberg Engineering, IvericBio, Kanghong, LinBioscience, Novartis, Oxurion, Pixium Vision, Oxurion, Stealth BioTherapeutics, Zeiss, Code C (Consultant/Contractor), Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, CenterVue, Ellex, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, NightStarX, Novartis, Optos, Pixium Vision, Zeiss, Code F (Financial Support);
Leon von der Emde Heidelberg Engineering, Code C (Consultant/Contractor)